CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 55 filers reported holding CHINA BIOLOGIC PRODS INC in Q3 2014. The put-call ratio across all filers is 3.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $3,761,000 | +10.5% | 33,251 | -2.2% | 1.89% | -13.8% |
| Q1 2017 | $3,405,000 | -14.4% | 34,001 | -8.1% | 2.19% | -20.5% |
| Q4 2016 | $3,978,000 | -13.6% | 37,001 | 0.0% | 2.76% | -25.8% |
| Q3 2016 | $4,606,000 | +17.1% | 37,001 | 0.0% | 3.72% | -1.2% |
| Q2 2016 | $3,934,000 | -46.3% | 37,001 | -42.2% | 3.76% | -24.2% |
| Q1 2016 | $7,327,000 | -52.8% | 64,001 | -41.2% | 4.96% | -15.6% |
| Q4 2015 | $15,514,000 | +56.7% | 108,901 | -1.2% | 5.88% | +52.1% |
| Q3 2015 | $9,898,000 | -34.0% | 110,201 | -15.4% | 3.87% | -23.6% |
| Q2 2015 | $14,994,000 | +42.5% | 130,201 | +18.1% | 5.06% | +38.8% |
| Q1 2015 | $10,525,000 | +42.1% | 110,201 | 0.0% | 3.65% | +21.1% |
| Q4 2014 | $7,409,000 | +24.6% | 110,201 | 0.0% | 3.01% | +1.0% |
| Q3 2014 | $5,946,000 | +21.3% | 110,201 | 0.0% | 2.98% | +19.5% |
| Q2 2014 | $4,901,000 | – | 110,201 | – | 2.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WARBURG PINCUS LLC | 10,989,200 | $1,049,578,000 | 7.88% |
| RUDMAN ERROL M | 110,201 | $10,525,000 | 3.65% |
| Ativo Capital Management LLC | 59,789 | $5,710,000 | 2.24% |
| OBERWEIS ASSET MANAGEMENT INC/ | 56,200 | $5,368,000 | 1.51% |
| Granite Point Capital Management, L.P. | 40,000 | $3,820,000 | 1.40% |
| Cormorant Asset Management, LP | 76,500 | $7,307,000 | 1.13% |
| Spark Investment Management LLC | 52,800 | $5,031,000 | 0.70% |
| Grandeur Peak Global Advisors, LLC | 33,050 | $3,157,000 | 0.67% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 198,454 | $18,954,000 | 0.66% |
| Visium Asset Management, LP | 438,008 | $41,834,000 | 0.62% |